Could umbilical cord stem cells repair damaged livers?
NCT ID NCT07413549
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether stem cells from umbilical cords can safely help people with severe liver scarring caused by hepatitis B. The trial involves 76 adults who will receive the stem cells through a vein. Researchers will check for side effects and measure if liver function improves.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- human umbilical cord mesenchymal stem cells
- What this could lead to
- If it works, this could offer a new way to improve liver function and reduce complications in people with advanced hepatitis B cirrhosis.
- What could go wrong
- This is an early phase 1-2 trial with only 76 participants, so results may not apply broadly. Stem cell treatments carry risks like infection or immune reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DECOMPENSATED HEPATITIS B CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongnan Hospital of Wuhan University
RECRUITINGWuhan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.